{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "a total of 32 extremities with rest pain or tissue loss requiring BKA will be enrolled"
      },
      "Participants": {
        "score": 2,
        "evidence": "32 extremities with rest pain or tissue loss requiring BKA"
      },
      "Intervention": {
        "score": 2,
        "evidence": "intramuscular (IM) injections of allogeneic MSCs (CHAMP, n=16) or autogenous concentrated bone marrow aspirate (cBMA, marrowCHAMP, n=16)"
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: Currently, there are no accepted nonsurgical therapies which improves the delivery of blood-derived nutrients to patients with critical limb ischemia (CLI)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Clinical limb perfusion pre- and post-treatment will be quantified using TcPO 2 , TBI, ABI, and indocyanine angiography (ICA)."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "subjects are randomized to BKA at four timepoints post-injection (days 3, 7, 14, 21)"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Enrollment is underway with ten patients treated per protocol thus far."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 10,
    "max_score": 25
  },
  "model": "gpt-4o"
}